SYNGEN BIOTECH CO.,LTD TW

Company Introduction: SYNGEN BIOTECH CO.,LTD TW

SYNGEN BIOTECH CO.,LTD is a biotechnology company based in Taiwan. The company specializes in the research, development, manufacturing, and marketing of in vitro diagnostic (IVD) products. Their primary focus is on rapid diagnostic test kits for human infectious diseases and animal health.

Classification: Factory (Manufacturer)

SYNGEN BIOTECH CO.,LTD operates as a manufacturer. They possess their own research and development capabilities and production facilities, indicating that they are directly involved in the creation and production of their diagnostic products.

SYNGEN BIOTECH CO.,LTD TW (杏國新藥股份有限公司) primarily focuses on the research and development of innovative new drugs, particularly in oncology. Their product pipeline includes:

SB05 (EndoTAG-1)

A liposomal paclitaxel formulation primarily developed for the treatment of pancreatic cancer.

SB01 (Genexol-PM)

A polymeric micelle formulation of paclitaxel, indicated for the treatment of breast cancer and non-small cell lung cancer. This product is licensed from another company.

SB02 (SB02-I)

A human epidermal growth factor receptor 2 (HER2) targeted antibody-drug conjugate (ADC) for HER2-positive cancers.

SB03 (SB03-I)

An orally available small molecule drug candidate targeting specific cancer pathways.

SB04 (SB04-I)

A small molecule drug candidate.